Shanghai Medical College

Company snapshot

Shanghai Medical College of Fudan University is a hospital & health care company based out of United Kingdom.

• 20 active pipeline program(s) linked via ClinicalTrials.gov.
• 20 trial update(s) in the last 12 months.

Public regulatory, clinical, patent, and corporate records for Shanghai Medical College. Not investment advice.

• Peer + 0 momentum

  Syndax Pharmaceuticals

  TA overlap score 29.4

• Peer + 0 momentum

  Actinium Pharmaceuticals

  TA overlap score 21.6

Recent activity

Latest pipeline, patent, and corporate events for Shanghai Medical College.

1. Jun 8, 2026 Clinical update

   temozolomide — Phase 2

2. Jun 8, 2026 Clinical update

   radiation therapy — Phase 2

3. Jun 8, 2026 Clinical update

   imatinib mesylate — Phase 1

4. Jun 8, 2026 Clinical update

   Doxorubicin Hydrochloride — Phase 2

5. Jun 8, 2026 Clinical update

   doxorubicin hydrochloride — Phase 3

View all clinical trial activity →

• What is Shanghai Medical College?

  Children's Hospital of is a pharma organization headquartered in CN. Primary therapeutic focus areas include Leukemia, Acute Myeloid Leukemia, Childhood Germ Cell Tumor, Juvenile Myelomonocytic Leukemia, Central Nervous System Nongerminomatous Germ Cell Tumor. NovaPharmaNews link

• Is Shanghai Medical College publicly traded?

  Shanghai Medical College appears in our database through regulatory marketing authorisation or clinical trial sponsor records; a US listed ticker is not shown for this entity.

• What drugs does Shanghai Medical College develop or market?

  We link 22 drug profile(s) where Shanghai Medical College is an originator or marketer in FDA or regional approval metadata. See the drug portfolio table on https://novapharmanews.com/companies/children-s-hospital-of-fudan-university#company-drugs.

• What are the latest developments for Shanghai Medical College?

  In the last 12 months our linked public records show 20 trial program update(s) and 0 US patent grant(s) tied to this profile.

• What therapeutic areas does Shanghai Medical College focus on?

  Shanghai Medical College focuses on Leukemia, Acute Myeloid Leukemia, Childhood Germ Cell Tumor based on our analysis of their pipeline programs and drug development activities.